Skip to playerSkip to main content
  • 2 weeks ago
Researchers at the University of Massachusetts Amherst are developing an electrical treatment aimed at the bladder lining, where recurrence can remain common. About 50% of patients experience recurrence within two years, according to Professor Govind Srimathveeravalli, whose lab is developing a catheter-based device. It uses electrical pulses intended to kill cells while preserving underlying tissue structure, and laboratory treatment takes approximately 10 minutes. Further development and validation are needed before human use, and whether the approach can reduce recurrence remains unknown.
Disclosure: This video contains stock footage and content created or enhanced using AI-assisted tools.

Category

🗞
News
Transcript
00:00About 50% of these bladder cancer patients experience recurrence within two years,
00:05says engineering professor Govind Sramath-Viravalli.
00:08But his team is testing a different way to tackle recurrence.
00:11At the University of Massachusetts Amherst,
00:14researchers are developing a catheter device that delivers electrical pulses.
00:19Instead of targeting hidden cancer cells individually,
00:22it would treat the bladder lining itself.
00:24The aim is to kill that cellular layer while preserving the tissue underneath.
00:28If that tissue is healthy, the team hypothesizes a healthy lining can regrow.
00:33But Sramath-Viravalli tells News Medical,
00:36We do not know that yet.
00:37His team envisions treatment after visible tumors are removed,
00:41before cancer grows into bladder muscle.
00:44Meanwhile, laboratory treatment takes approximately 10 minutes,
00:47though human use needs further development and validation.
00:51With five years of grant-supported research ahead,
00:54the goal remains fewer recurrences and fewer bladder removal.
00:58Disclosure, this video contains stock footage and content created or enhanced using AI-assisted tools.

Recommended